Paul Henderson,George D. Cimino,Chong-Xian Pan,Ralph William de Vere White,Maike Zimmermann,Kenneth W. Turteltaub
申请号：
US15742454
公开号：
US20180209984A1
申请日:
2016.07.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to methods, systems and kits for determining therapeutic effectiveness or toxicity of cancer-treating compounds that incorporate into or bind to DNA. In particular, the invention is directed to methods, systems and kits for predicting a patients treatment outcome after administration of a microdose of therapeutic composition to the patient. The methods provides physicians with a diagnostic tool to segregate cancer patients into differential populations that have a higher or lower chance of responding to a particular therapeutic treatment.
